STXS

Stereotaxis, Inc. develops and provides robotic systems for cardiac ablation procedures, utilizing remote magnetic navigation technology. The company's systems enhance precision and safety in treating various types of arrhythmias, allowing operators to navigate complex cardiac anatomy with improved control. Stereotaxis serves hospitals and healthcare providers, primarily in the field of electrophysiology, and operates in multiple global markets.